Ezetimibe ameliorates atherogenic lipids profiles, insulin resistance and hepatocyte growth factor in obese patients with hypercholesterolemia

The Effects of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Platelet and Inflammatory Biomarkers in Patients with Metabolic Syndrome

(2013) Michael Miller et al.   CARDIOLOGY

A comparison of efficacy and safety of an ezetimibe/simvastatin combination compared with other intensified lipid-lowering treatment strategies in diabetic patients with symptomatic cardiovascular disease

(2013) Jeffrey B Rosen et al.   Diabetes & Vascular Disease Research

Aldosterone, C-Reactive Protein, and Plasma B-Type Natriuretic Peptide Are Associated With the Development of Metabolic Syndrome and Longitudinal Changes in Metabolic Syndrome Components: Findings from the Jackson Heart Study

(2013) S. K. Musani et al.   DIABETES CARE

Low serum eicosapentaenoic acid / arachidonic acid ratio in male subjects with visceral obesity

(2013) Kana Inoue et al.   Nutrition & Metabolism

Prospective Study of Serum Adiponectin and Incident Metabolic Syndrome: The ARIRANG study

(2012) J.-Y. Kim et al.   DIABETES CARE

Effects of ezetimibe on visceral fat in the metabolic syndrome: a randomised controlled study

(2012) Hiroyuki Takase et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Double-Blind Randomized Clinical Trial of the Effects of Ezetimibe on Postprandial Hyperlipidaemia and Hyperglycaemia

(2012) Kaori Kikuchi et al.   Journal of Atherosclerosis and Thrombosis

Ezetimibe Ameliorates Atherosclerotic and Inflammatory Markers, Atherogenic Lipid Profiles, Insulin Sensitivity, and Liver Dysfunction in Japanese Patients with Hypercholesterolemia

(2012) Noboru Tamaki et al.   Journal of Atherosclerosis and Thrombosis

Lipid-altering efficacy of switching to ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk patients with and without metabolic syndrome

(2011) Maurizio Averna et al.   Diabetes & Vascular Disease Research

Plasma Aldosterone Levels and Development of Insulin Resistance

(2011) Eita Kumagai et al.   HYPERTENSION

The Effects of Ezetimibe on Surrogate Markers of Cholesterol Absorption and Synthesis in Japanese Patients with Dyslipidemia

(2011) Shinya Hiramitsu et al.   Journal of Atherosclerosis and Thrombosis

Ezetimibe Ameliorates Metabolic Disorders and Microalbuminuria in Patients with Hypercholesterolemia

(2011) Shusuke Yagi et al.   Journal of Atherosclerosis and Thrombosis

Remnant-like particle cholesterol and serum amyloid A–low-density lipoprotein levels in obese subjects with metabolic syndrome

(2011) Kazuhiko Kotani et al.   Journal of Clinical Lipidology

Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults

(2011) Ryuichi Kawamoto et al.   Lipids in Health and Disease

Relationships Between Metabolic Syndrome and Other Baseline Factors and the Efficacy of Ezetimibe/Simvastatin and Atorvastatin in Patients With Type 2 Diabetes and Hypercholesterolemia

(2010) R. B. Goldberg et al.   DIABETES CARE

Effects of Coadministered Ezetimibe Plus Fenofibrate in Mixed Dyslipidemic Patients with Metabolic Syndrome

(2010) Harold E. Bays et al.   Metabolic Syndrome and Related Disorders

Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Versus Atorvastatin in Patients With Hypercholesterolemia and the Metabolic Syndrome (from the VYMET Study)

(2009) Jennifer G. Robinson et al.   AMERICAN JOURNAL OF CARDIOLOGY

Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither

(2009) S. Conard et al.   DIABETES OBESITY & METABOLISM

Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL-profiles

(2009) K. Winkler et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients

(2008) Gideon R. Hajer et al.   ATHEROSCLEROSIS